Skip to main navigation Skip to search Skip to main content

Synthesis and preliminary in-vitro cytotoxic activity of novel substituted diaryl-imidazo [2, 1, b]-benzothiazole derivatives

  • Jitender K. Malik*
  • , Malleshappa N. Noolvi
  • , Fakkirappa V. Manvi
  • , B. K. Nanjwade
  • , Harun M. Patel
  • , S. N. Manjula
  • , Mallikarjuna C. Rao
  • , Ashutosh Barve
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

A novel series of substituted diaryl imidazo[2, 1-b]benzothiazole derivatives (8a-y) were synthesized by condensation reaction between 2-amino benzothiazole derivatives (3a-g) and substituted a-bromo-1, 2-(substituted) diaryl-1-ethanones (7a-i). The structures of the synthesized compounds were established by IR, 1H NMR, 13C NMR and mass spectroscopical data. The compounds (8a-y) were evaluated for their in-vitro cytotoxic activity on murine (B16F10) and human (MCF-7) cancer cells by using MTT assay. From the in vitro studies compounds 8p, 8u and 8y were found most effective with an IC50 range of 0.56-27.50 μM in MCF-7 and 2.57-36.54 μM in B16F10 cells.

Original languageEnglish
Pages (from-to)717-724
Number of pages8
JournalLetters in Drug Design and Discovery
Volume8
Issue number9
Publication statusPublished - 11-2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Synthesis and preliminary in-vitro cytotoxic activity of novel substituted diaryl-imidazo [2, 1, b]-benzothiazole derivatives'. Together they form a unique fingerprint.

Cite this